Lazarus; Robert A.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Lazarus; Robert A..The latest application filed is for "use of klk5 antagonists for treatment of a disease".
Company Profile
3.32.31
- Lazarus; Robert A. - Millbrae CA
- Lazarus; Robert A. - South San Francisco CA
- Lazarus; Robert A - Millbrae CA
- Lazarus; Robert A. - Milbrae CA
- Lazarus; Robert A. - San Mateo CA
Patent Activity
| Patent | Date |
|---|---|
| Chagasin-based scaffold compositions, methods, and uses Grant 10,562,946 - Lazarus , et al. Feb | 2020-02-18 |
| Use Of Klk5 Antagonists For Treatment Of A Disease App 20190078160 - Dressen; Amy ; et al. | 2019-03-14 |
| Methods And Compositions For Modulating Hgf/met App 20190054138 - Kirchhofer; Daniel K. ; et al. | 2019-02-21 |
| Method of reducing blood glucose by administering RON agonists Grant 10,005,848 - Egen , et al. June 26, 2 | 2018-06-26 |
| Nucleic acid molecules encoding for BACE1 antibodies Grant 9,879,094 - Atwal , et al. January 30, 2 | 2018-01-30 |
| Chagasin-based Scaffold Compositions, Methods, And Uses App 20170174733 - LAZARUS; Robert A. ; et al. | 2017-06-22 |
| Methods And Compositions For Modulating Hgf/met App 20170106042 - Kirchhofer; Daniel K. ; et al. | 2017-04-20 |
| Peptide inhibitors of BACE1 Grant 9,624,269 - Lazarus , et al. April 18, 2 | 2017-04-18 |
| Methods And Compositions For Neural Disease Immunotherapy App 20170058049 - Atwal; Jasvinder ; et al. | 2017-03-02 |
| Peptide Inhibitors Of Bace1 App 20160304563 - Lazarus; Robert A. ; et al. | 2016-10-20 |
| Methods and compositions for neural disease immunotherapy Grant 9,453,079 - Atwal , et al. September 27, 2 | 2016-09-27 |
| Ron Compositions And Methods Of Use Thereof App 20160032013 - EGEN; JACKSON G. ; et al. | 2016-02-04 |
| Peptide inhibitors of BACE1 Grant 9,193,766 - Lazarus , et al. November 24, 2 | 2015-11-24 |
| Methods And Compositions For Modulating Hgf/met App 20150126448 - Kirchhofer; Daniel K. ; et al. | 2015-05-07 |
| Methods And Compositions For Neural Disease Immunotherapy App 20140286963 - Atwal; Jasvinder ; et al. | 2014-09-25 |
| Peptide Inhibitors Of Bace1 App 20140228277 - Lazarus; Robert A. ; et al. | 2014-08-14 |
| BACE1 antibodies Grant 8,772,457 - Atwal , et al. July 8, 2 | 2014-07-08 |
| Variant Hhip1 protein and methods and uses thereof Grant 8,623,997 - Bosanac , et al. January 7, 2 | 2014-01-07 |
| Zymogen activators Grant 8,623,821 - Landgraf , et al. January 7, 2 | 2014-01-07 |
| Methods And Compositions For Modulating Hgf/met App 20130143813 - Kirchhofer; Daniel K. ; et al. | 2013-06-06 |
| Zymogen Activators App 20130096072 - Landgraf; Kyle E. ; et al. | 2013-04-18 |
| Methods And Compositions For Neural Disease Immunotherapy App 20120148599 - Atwal; Jasvinder ; et al. | 2012-06-14 |
| HGF .beta. chain variants Grant 8,110,377 - Kirchhofer , et al. February 7, 2 | 2012-02-07 |
| Methods And Compositions For Modulating Hgf/met App 20110177058 - Kirchhofer; Daniel K. ; et al. | 2011-07-21 |
| Variant Hhip1 Protein And Methods And Uses Thereof App 20110129457 - Bosanac; Ivan ; et al. | 2011-06-02 |
| Hgf Beta Chain Variants App 20100210826 - Kirchhofer; Daniel K. ; et al. | 2010-08-19 |
| HGF beta chain variants Grant 7,737,115 - Kirchhofer , et al. June 15, 2 | 2010-06-15 |
| Methods And Compositions For Modulating Hgf/met App 20100040634 - Kirchhofer; Daniel K. ; et al. | 2010-02-18 |
| Human Dnase I Hyperactive Variants App 20080293121 - Lazarus; Robert A. ; et al. | 2008-11-27 |
| Crystal Structure Of The Hepatocyte Growth Factor And Methods Of Use App 20080195366 - Eigenbrot; Charles W. ; et al. | 2008-08-14 |
| Human DNase I hyperactive variants Grant 7,407,785 - Lazarus , et al. August 5, 2 | 2008-08-05 |
| Enzymes for the production of 2-keto-L-gulonic acid Grant 7,256,027 - Lazarus , et al. August 14, 2 | 2007-08-14 |
| Methods And Compositions For Modulating Hgf/met App 20070129301 - Kirchhofer; Daniel K. ; et al. | 2007-06-07 |
| FVIIa antagonists Grant 7,164,002 - Lazarus , et al. January 16, 2 | 2007-01-16 |
| HGF beta chain variants App 20060293235 - Kirchhofer; Daniel K. ; et al. | 2006-12-28 |
| FVIIa antagonists Grant 7,084,109 - Dennis , et al. August 1, 2 | 2006-08-01 |
| Methods and compositions for modulating HGF/Met App 20060035278 - Kirchhofer; Daniel K. ; et al. | 2006-02-16 |
| Factor VIIa variants App 20060019893 - Maun; Henry R. ; et al. | 2006-01-26 |
| Crystal structure of the hepatocyte growth factor and methods of use App 20060003931 - Eigenbrot; Charles W. JR. ; et al. | 2006-01-05 |
| Human DNase I hyperactive variants App 20050170365 - Lazarus, Robert A. ; et al. | 2005-08-04 |
| Methods and compositions for modulating HGF/Met App 20050037431 - Kirchhofer, Daniel K. ; et al. | 2005-02-17 |
| FVIIa antagonists App 20040087767 - Lazarus, Robert A. ; et al. | 2004-05-06 |
| FVIIa antagonists App 20030119727 - Dennis, Mark S. ; et al. | 2003-06-26 |
| Human DNase I hyperactive variants App 20020173025 - Lazarus, Robert A. ; et al. | 2002-11-21 |
| Human DNase I hyperactive variants Grant 6,391,607 - Lazarus , et al. May 21, 2 | 2002-05-21 |
| Human DNase I variants Grant 6,348,343 - Lazarus , et al. February 19, 2 | 2002-02-19 |
| Human DNase I variants App 20010041360 - Lazarus, Robert A. ; et al. | 2001-11-15 |
| Pharmaceutical compositions containing ecotin and homologs thereof Grant 6,113,896 - Lazarus , et al. September 5, 2 | 2000-09-05 |
| Factor VIIa inhibitors from Kunitz domain proteins Grant 5,880,256 - Dennis , et al. March 9, 1 | 1999-03-09 |
| Factor VIIa inhibitors from kunitz domain proteins Grant 5,863,893 - Dennis , et al. January 26, 1 | 1999-01-26 |
| Pharmaceutical administration of ecotin homologs Grant 5,843,895 - Lazarus , et al. December 1, 1 | 1998-12-01 |
| Factor VIIa inhibitors from Kunitz domain proteins Grant 5,795,954 - Lazarus , et al. August 18, 1 | 1998-08-18 |
| Use of kunitz type plasma kallikrein inhibitors Grant 5,786,328 - Dennis , et al. July 28, 1 | 1998-07-28 |
| Factor viia inhibitors Grant 5,736,364 - Kelley , et al. April 7, 1 | 1998-04-07 |
| DNA encoding ecotin homologs Grant 5,719,041 - Lazarus , et al. February 17, 1 | 1998-02-17 |
| Enzymes for the production of 2-keto-L-gulonic acid Grant 5,583,025 - Lazarus , et al. December 10, 1 | 1996-12-10 |
| Enzymes for the production of 2-keto-L-gulonic acid Grant 5,376,544 - Lazarus , et al. December 27, 1 | 1994-12-27 |
| Platelet aggregation inhibitors from the leech Grant 5,227,469 - Lazarus , et al. July 13, 1 | 1993-07-13 |
| Metabolic pathway engineering to increase production of ascorbic acid intermediates Grant 5,032,514 - Anderson , et al. * July 16, 1 | 1991-07-16 |
| Ascorbic acid intermediates and process enzymes Grant 4,757,012 - Estell , et al. July 12, 1 | 1988-07-12 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 